AbCellera Biologics Inc.

ABCL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$5.83+2.10%

2026-08-03

Financials

Valuation Metrics

AbCellera Biologics Inc.'s Market Cap is $1.78B. At end of 2025 it was $1.02B. Ranked #2141 of 3,112 in US market (top 69%), #832 of 1,445 on NASDAQ (top 58%), #150 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 56%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.78B	US#2,141/3,112 Sec#150/269
Revenue	$79M	US#2,822/3,112 Sec#136/269
Net Income	$-144M	US—/3,112 Sec—/269
Total Assets	$1.31B	US#2,315/3,112 Sec#78/269
Net Assets	$938M	US#1,822/3,112 Sec#67/269
Value
P/B	1.90x	US#1,125/3,112 Sec#51/269
P/S	22.48x	US#2,830/3,112 Sec#150/269
FCF Yield	-10.63%	US—/3,112 Sec—/269
Profitability
ROE	-15.35%	US#2,471/3,112 Sec#94/269
ROA	-11.01%	US#2,659/3,112 Sec#102/269
Op. Margin	-267.61%	US#2,872/3,112 Sec#147/269
Revenue Growth	96.34%	US#153/3,112 Sec#33/269
Financial Health
Debt Ratio	39.34%	US#448/3,112 Sec#125/269
Total Debt	$140M	US#2,297/3,112 Sec#106/269
FCF	$-189M	US#2,724/3,112 Sec#215/269
Cash	$77M	US#2,359/3,112 Sec#195/269
Current Ratio	14.05x	US#169/3,112 Sec#55/269
Performance
1Y Return	37.50%	US#1,075/3,112 Sec#137/269
1M Return	-28.11%	US#3,051/3,112 Sec#254/269
From 52W High	-30.92%	US#2,208/3,112 Sec#167/269
1Y MDD	-54.94%	US#2,573/3,112 Sec#201/269
Trading
Volume	3,381,424 shares	US#559/3,112 Sec#42/269
Trading Value	$20M	US#1,971/3,112 Sec#149/269
Per Share
EPS	$-0.49	US—/3,112 Sec—/269
BPS	$3.82	US#2,331/3,112 Sec#148/269